EUVIMEDEUVIMED entdecken
Open Access

Targeted therapy‑associated cardiotoxicity in patients with stage‑IV lung cancer with or without cardiac comorbidities

Yanmei Peng, Dong Li, Jason A Wampfler, Yung-Hung Luo, Ashok V Kumar, Zhong Gu, Nikhila Kosuru, Nathan Y Yu, Zhichao Wang, Konstantinos Leventakos, Vinicius Ernani, Ping Yang

Oncology Reports · 2024

DOI: 10.3892/or.2024.8858 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, 2024. Verfasst von Yanmei Peng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Fangshan Hospital Beijing University of Chinese Medicine, Beijing 102400, P.R. China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Cardiotoxicity, Comorbidity. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsCardiotoxicityComorbidityMolecular Targeted TherapyHumansMaleFemaleAgedMiddle AgedNeoplasm StagingAged, 80 and overAdultProtein Kinase InhibitorsProspective StudiesAntineoplastic AgentsAcrylamidesHeart DiseasesAniline CompoundsErbB ReceptorsIndolesPyrimidines

Stichwörter der Autor:innen

cardiac comorbiditycardiotoxicitylung cancersurvivaltargeted therapy

Substanzen

Protein Kinase InhibitorsAntineoplastic AgentsAcrylamidesAniline CompoundsErbB ReceptorsosimertinibIndolesPyrimidines

Autor:innen und Institutionen

  • Department of Oncology, Fangshan Hospital Beijing University of Chinese Medicine, Beijing 102400, P.R. China.
  • Department of Cardiology, Dongfang Hospital, The Second Affiliated Hospital of Beijing University of Chinese Medicine, Beijing 100078, P.R. China.
  • Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA.
  • Department of Chest Medicine, Taipei Veterans General Hospital, Taipei 11217, Taiwan, R.O.C.
  • Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ 85259, USA.
  • Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ 85259, USA.

Förderung

  • NIA NIH HHS
  • NCI NIH HHS

Zitieren

APA

Peng, Y., Li, D., Wampfler, J. A., Luo, Y. H., Kumar, A. V., Gu, Z., Kosuru, N., Yu, N. Y., Wang, Z., Leventakos, K., Ernani, V., & Yang, P. (2024). Targeted therapy‑associated cardiotoxicity in patients with stage‑IV lung cancer with or without cardiac comorbidities. Oncology Reports. https://doi.org/10.3892/or.2024.8858

Vancouver

Peng Y, Li D, Wampfler JA, Luo YH, Kumar AV, Gu Z, et al. Targeted therapy‑associated cardiotoxicity in patients with stage‑IV lung cancer with or without cardiac comorbidities. Oncology Reports. 2024. doi:10.3892/or.2024.8858

BibTeX
@article{Peng2024,
  author = {Peng, Yanmei and Li, Dong and Wampfler, Jason A and Luo, Yung-Hung and Kumar, Ashok V and Gu, Zhong and Kosuru, Nikhila and Yu, Nathan Y and Wang, Zhichao and Leventakos, Konstantinos and Ernani, Vinicius and Yang, Ping},
  title = {Targeted therapy‑associated cardiotoxicity in patients with stage‑IV lung cancer with or without cardiac comorbidities},
  journal = {Oncology Reports},
  year = {2024},
  doi = {10.3892/or.2024.8858}
}
Kostenlos starten →